Povidone Iodine Pleurodesis for Refractory Congenital Chylothorax: A Review of Literature

##plugins.themes.academic_pro.article.sidebar##

Published Sep 20, 2017
Download
pdf
Vol. 94 No. 12 (2016): Issue Dec 2016

##plugins.themes.academic_pro.article.main##

Nadia kasdallah
Hakima Kbaier
Hatem Ben Salem
Sonia Blibech
Asma Bouziri
Mohamed Douagi

Abstract

Background: Povidone iodine (PVI) pleurodesis is commonly used in adult. However, this procedure is still nonconsensual in newborns.

Aims: This article aimed to report a new case of refractory congenital chylothorax (CCT) managed with PVI pleurodesis with a review of previousreported cases.

Methods: a systematic review of similar cases published in PubMed. Clinical patterns, therapeutic modalities and outcome variables werereported.

Result: In a full term neonate presenting refractory CCT, PVI pleurodesis was performed at day 16 of life by one intrapleural instillation of PVI4% with rapid success and no side effects. Renal function and thyroid tests stilled normal before and after instillation. The analysis of 18 casesreported in Medeline and our observation provided the following data: this procedure was successful without side effects in 11/19 cases. Severeside effects were reported in four patients with high risks before procedure.

Conclusion: PVI pleurodesis seems to be effective and inoffensive in the management of refractory CCT. It may be a good alternative tosurgery. Nevertheless, randomized studies on large neonatal population are required to precise: the risks and benefits of this procedure, thetiming and the modalities of its realization (duration of intervention, dilution and dosage of PVI) according to the patient`s field (gestational age,weight and associated morbidity).

Keywords:

Chemical pleurodesis, Povidone iodine, congenital chylothorax

##plugins.themes.academic_pro.article.details##

References

  1. Agarwal R, Khan A, Aggarwal AN, Gupta D. Efficacy & safety of iodopovidone pleurodesis: systematic review & meta-analysis. Indian J Med Res 2012;135(3):297.
  2. Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez J. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 2003;88(6):F531-F33.
  3. Mitanchez D, Walterâ€Nicolet E, Salomon R, Bavoux F, Hubert P. Congenital chylothorax: what is the best strategy? Arch Dis Child Fetal Neonatal Ed 2006;91(2):F153.
  4. Murki S, Faheemuddin M, Gaddam P. Congenital Chylothorax-Successful management with chemical pleurodesis. Indian J Pediatr 2010;77(3):332-34.
  5. Favre R, Becmeur F. Surgical management of congenital chylothorax in children. Eur J Pediatr Surg 2010;20:307-11.
  6. Hmami F, Oulmaati A, Bouchikhi C, Banani A, Bouharrou A. Congenital chylothorax: rapid and complete response to polyvidone iodine. Arch Pediatr 2014;21(9):1002-05.
  7. Scottoni F, Fusaro F, Conforti A, Morini F, Bagolan P. Pleurodesis with povidone-iodine for refractory chylothorax in newborns: Personal experience and literature review. J Pediatr Surg 2015; 50:1722-5.
  8. Resch B, Freidl T, Reiterer F. Povidone-iodine pleurodesis for congenital chylothorax of the newborn. Arch Dis Child Fetal Neonatal Ed 2015:fetalneonatal-2015309184.
  9. Maoulainine F, Slitine NE, Erguig L. Congenital Chylothorax: Rapid and Effective Response to Polyvidone Iodine. O J Ped 2016;6(01):10.
  10. Guo Y, Tang K, Bilaceroglu S, et al. Iodopovidone is as effective as doxycycline in producing pleurodesis in rabbits. Respirology 2010;15(1):119-25.